Inovio Pharmaceuticals (INO) Capital Expenditures (2010 - 2025)
Inovio Pharmaceuticals (INO) reported Capital Expenditures of $127,444 for Q4 2025, up 87.6% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Capital Expenditures (2010 - 2025) Analysis & Trends
For FY2025, Inovio Pharmaceuticals posted Capital Expenditures of $285,698, down 41.4% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -28.4% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $487,832 in FY2024 (+52.0%), $320,898 in FY2023 (-66.9%), $969,153 in FY2022 (-21.3%) and $1.23 million in FY2021 (-19.0%).
- The Q4 2025 figure ranks as the highest quarterly Capital Expenditures since Q2 2024.
- The high point for year-over-year Capital Expenditures in five years was Q2 2021 (growth of 484.3%); the low point was Q2 2023 (a decline of 96.7%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $67,951 (Q3 2025), $30,930 (Q2 2025) and $59,373 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Inovio Pharmaceuticals | 99.58 Mn | 99.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 127,444.00 |
| Sep 30, 2025 | 67,951.00 |
| Jun 30, 2025 | 30,930.00 |
| Mar 31, 2025 | 59,373.00 |
| Jun 30, 2024 | 452,254.00 |
| Mar 31, 2024 | 35,578.00 |
| Jun 30, 2023 | 23,915.00 |
| Mar 31, 2023 | 296,983.00 |
| Dec 31, 2022 | 165,109.00 |
| Sep 30, 2022 | 86,832.00 |
| Jun 30, 2022 | 717,212.00 |
| Dec 31, 2021 | 643,658.00 |
| Sep 30, 2021 | 168,614.00 |
| Jun 30, 2021 | 207,910.00 |
| Mar 31, 2021 | 210,824.00 |
| Dec 31, 2020 | 962,077.00 |
| Sep 30, 2020 | 382,054.00 |
| Jun 30, 2020 | 35,582.00 |
| Mar 31, 2020 | 140,952.00 |
| Dec 31, 2019 | 114,442.00 |
API Access
Inovio Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();